HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Anderson, H. L. Articles by Bartlett, R. H. Search for Related Content PubMed PubMed Citation Articles by Anderson, H. L., 3d Articles by Bartlett, R. H.

The Journal of Thoracic and Cardiovascular Surgery, Vol 99, 1011-1019, Copyright © 1990 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Extracorporeal membrane oxygenation for pediatric cardiopulmonary failure

HL Anderson 3d, RJ Attorri, JR Custer, RA Chapman and RH Bartlett
Department of Surgery, University of Michigan Medical Center, Ann Arbor 48109-0331.

Extracorporeal membrane oxygenation is now standard treatment of severe respiratory failure in newborn infants in our center (200 cases) and worldwide (over 2500 cases), but there are few reports of such trials in older children. We reviewed our experience with extracorporeal membrane oxygenation in 33 children aged 1 week to 18 years between 1971 and 1989. The modality was used when all other treatment failed. Extracorporeal membrane oxygenation provided excellent cardiopulmonary support for 1 to 25 days (average 7 1/2 days). The survival rate was 25% for cardiac support patients and 47% for respiratory failure patients (36% overall survival). Mechanical complications included membrane lung failure, tubing rupture, and pump failure, all managed without mortality. Physiologic complications included bleeding, pneumothorax, cardiac arrest, renal failure, hepatic failure, and brain injury. The major cause of death was irreversible injury to lung, heart, or brain. Extracorporeal life support is a reasonable approach for children with serious but reversible cardiopulmonary failure.

This article has been cited by other articles:

				G. Chow, B. Koirala, D. Armstrong, B. McCrindle, D. Bohn, D. Edgell, J. Coles, and G. de Veber Predictors of mortality and neurological morbidity in children undergoing extracorporeal life support for cardiac disease Eur J Cardiothorac Surg, July 1, 2004; 26(1): 38 - 43. [Abstract] [Full Text] [PDF]

				S. M. Langley, S. V. Sheppard, V. T. Tsang, J. L. Monro, and R. K. Lamb When is extracorporeal life support worthwhile following repair of congenital heart disease in children? Eur J Cardiothorac Surg, May 1, 1998; 13(5): 520 - 525. [Abstract] [Full Text] [PDF]

				H. L. Walters III, M. Hakimi, M. D. Rice, J. M. Lyons, G. C. Whittlesey, and M. D. Klein Pediatric cardiac surgical ECMO: Multivariate analysis of risk factors for hospital death Ann. Thorac. Surg., August 1, 1995; 60(2): 329 - 337. [Abstract] [PDF]

				R. I. Whyte, G. M. Deeb, K. R. McCurry, H. L. Anderson III, S. F. Boiling, and R. H. Bartlett Extracorporeal life support after heart or lung transplantation Ann. Thorac. Surg., September 1, 1994; 58(3): 754 - 758. [Abstract] [PDF]

				D. G. Pennington and M. T. Swartz Circulatory support in infants and children Ann. Thorac. Surg., January 1, 1993; 55(1): 233 - 237. [Abstract] [PDF]

				H. L. Anderson, R. E. Delius, J. M. Sinard, K. R. McCurry, C. J. Shanley, R. A. Chapman, M. B. Shapiro, J. L. Rodriguez, and R. H. Bartlett Early experience with adult extracorporeal membrane oxygenation in the modern era Ann. Thorac. Surg., April 1, 1992; 53(4): 553 - 563. [Abstract] [PDF]

				R. E. Delius, J. B. Zwischenberger, R. Cilley, D. M. Behrendt, E. L. Bove, G. M. Deeb, D. Crowley, K. P. Heidelberger, and R. H. Bartlett Prolonged extracorporeal life support of pediatric and adolescent cardiac transplant patients Ann. Thorac. Surg., November 1, 1990; 50(5): 791 - 795. [Abstract] [PDF]